Siemens has invested in Amply as part of a $13.2m round that came just three months after the EV charging service closed its seed funding.

The energy monitor developer secured $11.8m in a round co-led by Constellation Technology Ventures and backed by Chevron Technology Ventures.

Boehringer Ingelheim Venture Fund co-led a series A round set to drive clinical work on UC Berkeley-founded Actym Therapeutics' immunotherapy pipeline.

Boehringer Ingelheim Venture Fund co-led the cancer immunotherapy developer's series A round, which also featured Illumina Ventures.

The online insurance provider received $13.5m in a round led by Centauri Fund and backed by MassMutual Ventures, MDI Ventures and Central Capital Ventura.

Repeatome drug developer Rome Therapeutics is based on intellectual property from Massachusetts General Hospital and Icahn School of Medicine at Mount Sinai.

JHU-founded restorative materials technology developer Lifesprout secured $28.5m in a round led by Redmile Group as it looks to move into regenerative medicine.

Medytox-backed restorative materials technology developer Lifesprout secured $28.5m in a round led by Redmile Group as it looks to move into regenerative medicine.

Repeatome drug developer Rome Therapeutics was incubated within GV, which took part in the series A round along with fellow corporate unit Partners Innovation Fund.

GLP and G7 - two of the three corporates that co-founded autonomous fleet software developer Inceptio - have contributed to its series A round.